The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Update of TTD: Therapeutic Target Database
Open accessAbstract
Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets, hundreds of which are targets of approved and clinical trial drugs. Knowledge of these targets and corresponding drugs, particularly those in clinical uses and trials, is highly useful for facilitating drug discovery. Therapeutic Target Database (TTD) has been developed to provide information about therapeutic targets and corresponding drugs. In order to accommodate increasing demand for comprehensive knowledge about the primary targets of the approved, clinical trial and experimental drugs, numerous improvements and updates have been made to TTD. These updates include information about 348 successful, 292 clinical trial and 1254 research targets, 1514 approved, 1212 clinical trial and 2302 experimental drugs linked to their primary targets (3382 small molecule and 649 antisense drugs with available structure and sequence), new ways to access data by drug mode of action, recursive search of related targets or drugs, similarity target and drug searching, customized and whole data download, standardized target ID, and significant increase of data (1894 targets, 560 diseases and 5028 drugs compared with the 433 targets, 125 diseases and 809 drugs in the original release described in previous paper). This database can be accessed at http://bidd.nus.edu.sg/group/cjttd/TTD.asp.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Willett, P., Barnard, J. M., & Downs, G. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9800211 · Cited by 1,765
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Benchmarking sets for molecular docking.
Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Mechanisms of drug combinations: interaction and network perspectives
Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2683 · Cited by 969
Self-citationDrugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
TTD: Therapeutic Target Database
Chen, X. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.412 · Cited by 716
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Lindsay, M. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1202 · Cited by 332
Elucidating mechanisms of drug-induced toxicity
Liebler, D. C., & Guengerich, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1720 · Cited by 323
PDTD: a web-accessible protein database for drug target identification
Gao, Z., Li, H., Zhang, H., Liu, X., Kang, L., Luo, X., Zhu, W., Chen, K., Wang, X., & Jiang, H. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-104 · Cited by 288
Self-citationTherapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics
Zheng, C. J., Han, L. Y., Yap, C. W., Ji, Z. L., Cao, Z. W., & Chen, Y. Z. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.4 · Cited by 185
Self-citationDo Structurally Similar Ligands Bind in a Similar Fashion?
Boström, J., Hogner, A., & Schmitt, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060167o · Cited by 180
Functional genomics to new drug targets
Kramer, R., & Cohen, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1552 · Cited by 170
Trapping Moving Targets with Small Molecules
Lee, G., & Craik, C. S. (2009) · Science · doi:10.1126/science.1169378 · Cited by 147
Evolution of protein sequences and structures
Wood, T. C., & Pearson, W. R. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2972 · Cited by 132
Drug Discovery in the Next Millennium
Ohlstein, E. H., Ruffolo, R. R., Jr., & Elliott, J. D. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.177 · Cited by 128
DISEASE GENE DISCOVERY THROUGH INTEGRATIVE GENOMICS
Giallourakis, C. C., Henson, C., Reich, M. M., Xie, X. S., & Mootha, V. K. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162234 · Cited by 84
Han, L., Zheng, C., Xie, B., Jia, J., Xiao, H., Zhu, F., Lin, H., Chen, X., & Chen, Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.02.015 · Cited by 74
Self-citationSequence Variations within Protein Families are Linearly Related to Structural Variations
Koehl, P., & Levitt, M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00971-3 · Cited by 67
Protein domain identification and improved sequence similarity searching using PSI‐BLAST
George, R. A., & Heringa, J. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10175 · Cited by 65
Gerstein, M. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.8.707 · Cited by 57
Zhu, F., Han, L., Zheng, C., Xie, B., Tammi, M. T., Yang, S., Wei, Y., & Chen, Y. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149955 · Cited by 50
Self-citationLarge-Scale Structural Biology of the Human Proteome
Edwards, A. M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.070907.103305 · Cited by 46
H., X., Wang, R., Yang, S. Y., Li, Z., Xue, Y. W., Wei, Y., Low, B. C., & Chen, Y. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800022e · Cited by 42
Self-citationMolecular Modeling as a Tool for Drug Discovery
Barcellos, G. B., Pauli, I., Caceres, R. A., Timmers, L. F. S. M., Dias, R., & de Azevedo, W. F. (2008) · Current Drug Targets · doi:10.2174/138945008786949388 · Cited by 21
Prioritizing the human genome: knowledge management for drug discovery.
Golden, J. B. (2003) · PubMed · Cited by 20
Structural Genomics: The Ultimate Approach for Rational Drug Design
Lundstrom, K. H. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:205 · Cited by 13
Cited by
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
DGIdb: mining the druggable genome
Griffith, M., Griffith, O. L., Coffman, A. C., Weible, J. V., McMichael, J. F., Spies, N. C., Koval, J., Das, I., Callaway, M. B., Eldred, J. M., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2689 · Cited by 533
Li, Y. H., Yu, C. Y., Li, X. X., Zhang, P., Tang, J., Yang, Q., Fu, T., Zhang, X., Cui, X., Tu, G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1076 · Cited by 523
Self-citationTherapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
Zhu, F., Shi, Z., Qin, C., Tao, L., Liu, X., Xu, F., Zhang, L., Song, Y., Liu, X., Zhang, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr797 · Cited by 480
Self-citationRecognizing Pitfalls in Virtual Screening: A Critical Review
Scior, T., Bender, A., Tresadern, G., Medina-Franco, J. L., Martínez-Mayorga, K., Langer, T., Cuanalo-Contreras, K., & Agrafiotis, D. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200528d · Cited by 438
Metadata
- Authors
- Zhu, F., Han, B., Kumar, P., Liu, X., Ma, X., Wei, X., Huang, L., Guo, Y., Han, L., Zheng, C., & Chen, Y.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-20
- Volume
- 38
- Issue
- suppl_1
- Pages
- D787-D791
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2069676201
- Cited by
- 274
- References
- 34
- FWCI
- 18.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.